Synopsis of recent research by authors named "Yifei Qian"
* The studies highlight potential therapeutic vulnerabilities in TP53-mutated liver cancer and propose innovative strategies to enhance the effectiveness of immune checkpoint blockade (ICB) and targeted therapies like lenvatinib.
* Additionally, Qian explores complementary areas such as the pharmacological mechanisms of traditional Chinese medicine in treating conditions like perianal eczema and advancements in automated animal counting in ecological research through aerial imaging.